Advanced glycation end-product-mediated protein crosslinks (AGE crosslinks)

Advanced glycation end-product (AGE)-mediated protein crosslinks are covalent bonds formed through non-enzymatic glycation (the Maillard reaction) between reducing sugars and the amino groups of long-lived extracellular matrix (ECM) proteins, such as collagen and elastin. These modifications accumulate naturally with age but are significantly accelerated in pathological states like diabetes mellitus due to chronic hyperglycemia. The formation of these crosslinks leads to the progressive stiffening of tissues, particularly in the vasculature, heart, and kidneys, which contributes to hypertension, diastolic heart failure, and renal dysfunction (Source: NIH/PMC2646053). Beyond structural changes, AGE-modified proteins can interact with the Receptor for Advanced Glycation End-products (RAGE), triggering pro-inflammatory and pro-oxidative signaling pathways that further exacerbate tissue damage (Source: PubMed PMID: 11738412). Therapeutic strategies have focused on 'AGE breakers' like Alagebrium, which aim to cleave established crosslinks to restore organ elasticity, and inhibitors like Aminoguanidine that prevent their formation. While early clinical results showed promise in reducing arterial stiffness, the complexity and chemical diversity of AGEs, particularly the prevalence of stable crosslinks like glucosepane, remain significant challenges for drug development (Source: PubMed PMID: 26183576).

Other names

Advanced glycation end-product crosslinksAGE-mediated extracellular matrix crosslinkingGlycation-induced protein crosslinksMaillard reaction productsGlucosepane crosslinksPentosidine crosslinks

Pharmacological agents targeting these crosslinks generally act as either 'AGE breakers,' which chemically cleave existing alpha-diketone-based crosslinks to restore tissue flexibility, or 'AGE inhibitors,' which scavenge reactive carbonyl intermediates to prevent the initial formation of crosslinks on long-lived proteins like collagen (Source: PubMed PMID: 12540603, 11500470).